Daniel Molin – Klinisk och translationell forskning inom lymfom, speciellt Hodgkins lymfom

Accounting for out-of-field dose and second cancer risk in classical Hodgkin lymphoma: A comprehensive comparison of proton and photon therapy using whole-body phantom

Azizi, Mona; Romero-Expósito, Maite; Jafarian-Dehkordi, Forough; Muñoz-Hernández, Isidora S. et al.

Ingår i Physica medica (Testo stampato), 2026

• DOI för Accounting for out-of-field dose and second cancer risk in classical Hodgkin lymphoma: A comprehensive comparison of proton and photon therapy using whole-body phantom
• Ladda ner fulltext (pdf) av Accounting for out-of-field dose and second cancer risk in classical Hodgkin lymphoma: A comprehensive comparison of proton and photon therapy using whole-body phantom

AVD is an effective chemotherapy backbone in first-line treatment of older patients with classical Hodgkin lymphoma

Övergaard, Ninja; Lia, Kjersti; Collin, Jeremia; Asdahl, Peter H. et al.

Ingår i Blood Advances, s. 4889-4897, 2026

• DOI för AVD is an effective chemotherapy backbone in first-line treatment of older patients with classical Hodgkin lymphoma
• Ladda ner fulltext (pdf) av AVD is an effective chemotherapy backbone in first-line treatment of older patients with classical Hodgkin lymphoma

Exploratory study linking plasma proteomics to cardiotoxicity in Hodgkin lymphoma

Mattson Ulfstedt, Johan; Risebro, Ragnhild; Freyhult, Eva; Christersson, Christina et al.

Ingår i Cardio-Oncology, 2026

• DOI för Exploratory study linking plasma proteomics to cardiotoxicity in Hodgkin lymphoma
• Ladda ner fulltext (pdf) av Exploratory study linking plasma proteomics to cardiotoxicity in Hodgkin lymphoma

Glowing evidence: radiation shines in early NLPHL

Molin, Daniel

Ingår i Blood Advances, s. 5411-5412, 2026

• DOI för Glowing evidence: radiation shines in early NLPHL
• Ladda ner fulltext (pdf) av Glowing evidence: radiation shines in early NLPHL

Mortality in Patients With Hodgkin Lymphoma and Heart Failure: A Swedish Population-Based Study

Godtfredsen, Sissel Johanne; Eloranta, Sandra; Smedby, Karin E.; Antonilli, Stefanie et al.

Ingår i JACC: Advances, 2026

• DOI för Mortality in Patients With Hodgkin Lymphoma and Heart Failure: A Swedish Population-Based Study
• Ladda ner fulltext (pdf) av Mortality in Patients With Hodgkin Lymphoma and Heart Failure: A Swedish Population-Based Study

Neoehrlichia mikurensis infection associated with lymphoma or mimicking lymphoma in two cohorts of Swedish patients

Wenneras, Christine; Alsalihi, Rima; Karlsson, Veronica; Lewerin, Catharina et al.

Ingår i Leukemia and Lymphoma, s. 1327-1334, 2026

• DOI för Neoehrlichia mikurensis infection associated with lymphoma or mimicking lymphoma in two cohorts of Swedish patients
• Ladda ner fulltext (pdf) av Neoehrlichia mikurensis infection associated with lymphoma or mimicking lymphoma in two cohorts of Swedish patients

Personalized organ dose assessment from CT imaging during proton therapy for classical Hodgkin lymphoma patients

Gkavonatsiou, Angeliki; Romero-Expósito, Maite; Andersson, Karin M.; Azizi, Mona et al.

Ingår i Physica medica (Testo stampato), 2026

• DOI för Personalized organ dose assessment from CT imaging during proton therapy for classical Hodgkin lymphoma patients
• Ladda ner fulltext (pdf) av Personalized organ dose assessment from CT imaging during proton therapy for classical Hodgkin lymphoma patients

A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphoma

Lia, Kjersti; Jørgensen, Rasmus Rask Kragh; Wikman, Per; Wold, Bente L. et al.

Ingår i Haematologica, s. 2356-2366, 2025

• DOI för A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphoma
• Ladda ner fulltext (pdf) av A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphoma

Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials

Viviani, Simonetta; Pavoni, Chiara; Barrington, Sally F.; Guerra, Luca et al.

Ingår i Blood Cancer Journal, 2025

• DOI för Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials
• Ladda ner fulltext (pdf) av Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials

Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients

Broeckelmann, Paul J.; Boell, Boris; Molin, Daniel; Schneider, Gundolf et al.

Ingår i HemaSphere, 2025

• DOI för Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients

Brentuximab vedotin monotherapy is a feasible and effective treatment for older patients with classical Hodgkin lymphoma unsuitable for curative chemotherapy: Results from the prospective GHSG-NLG phase II BVB trial

Fossa, Alexander; Molin, Daniel; Broeckelmann, Paul J.; Schneider, Gundolf et al.

Ingår i HemaSphere, 2025

• DOI för Brentuximab vedotin monotherapy is a feasible and effective treatment for older patients with classical Hodgkin lymphoma unsuitable for curative chemotherapy: Results from the prospective GHSG-NLG phase II BVB trial
• Ladda ner fulltext (pdf) av Brentuximab vedotin monotherapy is a feasible and effective treatment for older patients with classical Hodgkin lymphoma unsuitable for curative chemotherapy: Results from the prospective GHSG-NLG phase II BVB trial

Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: a secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trial

Ferdinandus, Justin; Schneider, Gundolf; Moccia, Alden; Greil, Richard et al.

Ingår i The Lancet Oncology, s. 1081-1090, 2025

• DOI för Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: a secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trial
• Ladda ner fulltext (pdf) av Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: a secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trial

Improved therapies, incomplete data: late toxicity after modern classical Hodgkin Lymphoma radiotherapy

Molin, Daniel

Ingår i Acta Oncologica, s. 1540-1543, 2025

• DOI för Improved therapies, incomplete data: late toxicity after modern classical Hodgkin Lymphoma radiotherapy
• Ladda ner fulltext (pdf) av Improved therapies, incomplete data: late toxicity after modern classical Hodgkin Lymphoma radiotherapy

Individualized evaluation of the total dose received by radiotherapy patients: Integrating in-field, out-of-field, and imaging doses

Romero-Expósito, Maite; Sánchez-Nieto, Beatriz; Riveira-Martin, Mercedes; Azizi, Mona et al.

Ingår i Physica medica (Testo stampato), 2025

• DOI för Individualized evaluation of the total dose received by radiotherapy patients: Integrating in-field, out-of-field, and imaging doses
• Ladda ner fulltext (pdf) av Individualized evaluation of the total dose received by radiotherapy patients: Integrating in-field, out-of-field, and imaging doses

Response to Comment on: "A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphoma"

Lia, Kjersti; Rask Kragh Jorgensen, Rasmus; Wikman, Per; Wold, Bente L. et al.

Ingår i Haematologica, s. 2866-2867, 2025

• DOI för Response to Comment on: "A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphoma"
• Ladda ner fulltext (pdf) av Response to Comment on: "A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphoma"

Aging Kairos: treating older Hodgkin patients

Molin, Daniel

Ingår i Blood, s. 943-945, 2024

• DOI för Aging Kairos: treating older Hodgkin patients

Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial

Borchmann, Peter; Ferdinandus, Justin; Schneider, Gundolf; Moccia, Alden et al.

Ingår i The Lancet, s. 341-352, 2024

• DOI för Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial
• Ladda ner fulltext (pdf) av Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial

Congestive heart failure after anthracycline-containing treatment for Hodgkin lymphoma: A Swedish matched cohort study

Baech, Joachim; El-Galaly, Tarec Christoffer; Entrop, Joshua P.; Glimelius, Ingrid et al.

Ingår i eJHaem, s. 1190-1200, 2024

• DOI för Congestive heart failure after anthracycline-containing treatment for Hodgkin lymphoma: A Swedish matched cohort study
• Ladda ner fulltext (pdf) av Congestive heart failure after anthracycline-containing treatment for Hodgkin lymphoma: A Swedish matched cohort study

Diagnostik och behandling av klassiskt Hodgkins lymfom

Molin, Daniel

Ingår i Läkartidningen, 2024

Evaluation of coverage, generalisability and validity of the U-CAN lymphoma biobank in Sweden: A comparison with nationwide registers

Forsgren, Elin; Ekberg, Sara; Smedby, Karin E.; Nylund, Patrick et al.

Ingår i British Journal of Haematology, s. 1794-1803, 2024

• DOI för Evaluation of coverage, generalisability and validity of the U-CAN lymphoma biobank in Sweden: A comparison with nationwide registers
• Ladda ner fulltext (pdf) av Evaluation of coverage, generalisability and validity of the U-CAN lymphoma biobank in Sweden: A comparison with nationwide registers

Impact of the COVID-19 pandemic on lymphoma incidence and short-term survival - a Swedish Lymphoma Register Study

Ekberg, Sara; Molin, Daniel; Pahnke, Simon; Bergstroem, Fanny et al.

Ingår i Acta Oncologica, s. 164-168, 2024

• DOI för Impact of the COVID-19 pandemic on lymphoma incidence and short-term survival - a Swedish Lymphoma Register Study
• Ladda ner fulltext (pdf) av Impact of the COVID-19 pandemic on lymphoma incidence and short-term survival - a Swedish Lymphoma Register Study

Improved automated tumor segmentation in whole-body 3D scans using multi-directional 2D projection-based priors

Tarai, Sambit; Lundström, Elin; Sjöholm, Therese; Jönsson, Hanna et al.

Ingår i Heliyon, 2024

• DOI för Improved automated tumor segmentation in whole-body 3D scans using multi-directional 2D projection-based priors
• Ladda ner fulltext (pdf) av Improved automated tumor segmentation in whole-body 3D scans using multi-directional 2D projection-based priors

Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial

Luminari, Stefano; Fossa, Alexander; Trotman, Judith; Molin, Daniel et al.

Ingår i Journal of Clinical Oncology, s. 13-18, 2024

• DOI för Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial
• Ladda ner fulltext (pdf) av Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial

The National Swedish Lymphoma Register - a systematic validation of data quality

Smedby, Karin E.; Eloranta, Sandra; Wasterlid, Tove; Falini, Victor et al.

Ingår i Acta Oncologica, s. 563-572, 2024

• DOI för The National Swedish Lymphoma Register - a systematic validation of data quality
• Ladda ner fulltext (pdf) av The National Swedish Lymphoma Register - a systematic validation of data quality

Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma

Armand, Philippe; Zinzani, Pier Luigi; Lee, Hun Ju; Johnson, Nathalie A. et al.

Ingår i Blood, s. 878-886, 2023

• DOI för Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma

NLPHL: a hummingbird in an owl's nest

Molin, Daniel

Ingår i Blood, s. 499-500, 2023

• DOI för NLPHL: a hummingbird in an owl's nest

Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway-A population-based matched cohort study

Entrop, Joshua P.; Weibull, Caroline E.; Smedby, Karin E.; Jakobsen, Lasse H. et al.

Ingår i International Journal of Cancer, s. 723-731, 2023

• DOI för Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway-A population-based matched cohort study
• Ladda ner fulltext (pdf) av Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway-A population-based matched cohort study

Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma

Nikkarinen, Anna; Lokhande, Lavanya; Amini, Rose-Marie; Jerkeman, Mats et al.

Ingår i Blood Advances, s. 5304-5313, 2023

• DOI för Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma

An image registration method for voxel-wise analysis of whole-body oncological PET-CT

Jönsson, Hanna; Ekström, Simon; Strand, Robin; Pedersen, Mette A et al.

Ingår i Scientific Reports, 2022

• DOI för An image registration method for voxel-wise analysis of whole-body oncological PET-CT
• Ladda ner fulltext (pdf) av An image registration method for voxel-wise analysis of whole-body oncological PET-CT

Checkpoint CD47 expression in classical Hodgkin lymphoma

Gholiha, Alex Reza; Hollander, Peter; Löf, Liza; Glimelius, Ingrid et al.

Ingår i British Journal of Haematology, s. 580-589, 2022

• DOI för Checkpoint CD47 expression in classical Hodgkin lymphoma
• Ladda ner fulltext (pdf) av Checkpoint CD47 expression in classical Hodgkin lymphoma

Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity

Hellbacher, Erik; Sundström, Christer; Molin, Daniel; Baecklund, Eva et al.

Ingår i Cancers, 2022

• DOI för Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity
• Ladda ner fulltext (pdf) av Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity

Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue

Gholiha, Alex R.; Hollander, Peter; Löf, Liza; Larsson, Anders et al.

Ingår i Cancers, 2022

• DOI för Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue
• Ladda ner fulltext (pdf) av Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue

Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy

Lagerlöf, Ingemar; Fohlin, Helena; Enblad, Gunilla; Glimelius, Bengt et al.

Ingår i Journal of Clinical Oncology, s. 1487-1496, 2022

• DOI för Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy
• Ladda ner fulltext (pdf) av Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy

Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls

Sabaa, Amal Abu; Shen, Qiujin; Lennmyr, Emma; Enblad, Anna Pia et al.

Ingår i New Biotechnology, s. 21-29, 2022

• DOI för Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls
• Ladda ner fulltext (pdf) av Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls

High risk of cardiovascular side effects after treatment of Hodgkin's lymphoma - is there a need for intervention in long-term survivors?

Andersson, Anne; Enblad, Gunilla; Erlanson, Martin; Johansson, Ann-Sofie et al.

Ingår i Upsala Journal of Medical Sciences, 2021

• DOI för High risk of cardiovascular side effects after treatment of Hodgkin's lymphoma - is there a need for intervention in long-term survivors?
• Ladda ner fulltext (pdf) av High risk of cardiovascular side effects after treatment of Hodgkin's lymphoma - is there a need for intervention in long-term survivors?

Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma

Mörth, Charlott; Sabaa, Amal Abu; Freyhult, Eva; Christersson, Christina et al.

Ingår i Cardio-Oncology, 2021

• DOI för Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma
• Ladda ner fulltext (pdf) av Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma

Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders

Kinch, Amelie; Baecklund, Eva; Molin, Daniel; Pauksen, Karlis et al.

Ingår i Acta Oncologica, s. 771-778, 2021

• DOI för Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders
• Ladda ner fulltext (pdf) av Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders

Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma

Vajavaara, Heli; Ekeblad, Frida; Holte, Harald; Jorgensen, Judit et al.

Ingår i Haematologica, s. 2502-2506, 2021

• DOI för Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma
• Ladda ner fulltext (pdf) av Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma

Real-world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000-2014, focusing on patients aged >60 years

Wahlin, Bjoern Engelbrekt; Övergaard, Ninja; Peterson, Stefan; Digkas, Evangelos et al.

Ingår i eJHaem, s. 400-412, 2021

• DOI för Real-world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000-2014, focusing on patients aged >60 years
• Ladda ner fulltext (pdf) av Real-world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000-2014, focusing on patients aged >60 years

Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma

Gholiha, Alex R.; Hollander, Peter; Glimelius, Ingrid; Hedström, Gustaf et al.

Ingår i Blood Advances, s. 1671-1681, 2021

• DOI för Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma

Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma

Mattsson Ulfstedt, Johan; Venge, Per; Holmgren, Sofia; Enblad, Gunilla et al.

Ingår i Upsala Journal of Medical Sciences, 2021

• DOI för Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma
• Ladda ner fulltext (pdf) av Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma

CD30 expression and survival in posttransplant lymphoproliferative disorders

Kinch, Amelie; Amini, Rose-Marie; Hollander, Peter; Molin, Daniel et al.

Ingår i Acta Oncologica, s. 673-680, 2020

• DOI för CD30 expression and survival in posttransplant lymphoproliferative disorders
• Ladda ner fulltext (pdf) av CD30 expression and survival in posttransplant lymphoproliferative disorders

Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real-world patients

Jakobsen, Lasse H.; Ellin, Fredrik; Smeland, Knut B.; Wästerlid, Tove et al.

Ingår i British Journal of Haematology, s. 661-671, 2020

• DOI för Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real-world patients

No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy

Lagerlöf, Ingemar; Holte, Harald; Glimelius, Ingrid; Björkholm, Magnus et al.

Ingår i British Journal of Haematology, s. 685-691, 2020

• DOI för No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy

Pembrolizumab in relapsed or refractory Richter syndrome

Armand, Philippe; Murawski, Niels; Molin, Daniel; Zain, Jasmine et al.

Ingår i British Journal of Haematology, 2020

• DOI för Pembrolizumab in relapsed or refractory Richter syndrome
• Ladda ner fulltext (pdf) av Pembrolizumab in relapsed or refractory Richter syndrome

Pembrolizumab monotherapy in patients with primary refractory classical hodgkin lymphoma who relapsed after salvage autologous stem cell transplantation and/or brentuximab vedotin therapy: KEYNOTE-087 subgroup analysis

Zinzani, Pier Luigi; Chen, Robert; Armand, Philippe; Johnson, Nathalie A. et al.

Ingår i Leukemia and Lymphoma, s. 950-954, 2020

• DOI för Pembrolizumab monotherapy in patients with primary refractory classical hodgkin lymphoma who relapsed after salvage autologous stem cell transplantation and/or brentuximab vedotin therapy: KEYNOTE-087 subgroup analysis

Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma

Hollander, Peter; Ginman, Beatrice; Molin, Daniel; Enblad, Gunilla et al.

Ingår i Immunobiology, 2020

• DOI för Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma
• Ladda ner fulltext (pdf) av Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma

Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation

Kinch, Amelie; Sundström, Christer; Baecklund, Eva; Backlin, Carin et al.

Ingår i Leukemia and Lymphoma, s. 376-384, 2019

• DOI för Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation
• Ladda ner fulltext (pdf) av Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation

Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapy

Pedersen, Mette A.; Gormsen, Lars C.; Kamper, Peter; Wassberg, Cecilia et al.

Ingår i British Journal of Haematology, s. 431-439, 2019

• DOI för Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapy

High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B-symptoms

Gholiha, Alex R.; Hollander, Peter; Hedström, Gustaf; Sundström, Christer et al.

Ingår i British Journal of Haematology, s. 192-201, 2019

• DOI för High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B-symptoms

Intratumoral expression of FoxP3-positive regulatory T-cells in T-cell lymphoma: no correlation with survival

Lundberg, Josefine; Berglund, David; Molin, Daniel; Kinch, Amelie

Ingår i Upsala Journal of Medical Sciences, s. 105-110, 2019

• DOI för Intratumoral expression of FoxP3-positive regulatory T-cells in T-cell lymphoma: no correlation with survival
• Ladda ner fulltext (pdf) av Intratumoral expression of FoxP3-positive regulatory T-cells in T-cell lymphoma: no correlation with survival

Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087

Chen, Robert; Zinzani, Pier Luigi; Lee, Hun Ju; Armand, Philippe et al.

Ingår i Blood, s. 1144-1153, 2019

• DOI för Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087

An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome

Hollander, Peter; Rostgaard, Klaus; Ekström-Smedby, Karin; Molin, Daniel et al.

Ingår i European Journal of Haematology, s. 88-97, 2018

• DOI för An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome
• Ladda ner fulltext (pdf) av An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome

Does the omission of vincristine in patients with diffuse large B cell lymphoma affect treatment outcome?

Mörth, Charlott; Valachis, Antonis; Sabaa, Amal Abu; Molin, Daniel et al.

Ingår i Annals of Hematology, s. 2129-2135, 2018

• DOI för Does the omission of vincristine in patients with diffuse large B cell lymphoma affect treatment outcome?
• Ladda ner fulltext (pdf) av Does the omission of vincristine in patients with diffuse large B cell lymphoma affect treatment outcome?

Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma

Hollander, Peter; Amini, Rose-Marie; Ginman, Beatrice; Molin, Daniel et al.

Ingår i PLOS ONE, 2018

• DOI för Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma
• Ladda ner fulltext (pdf) av Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma

Hodgkin lymphoma in children, adolescents and young adults - a comparative study of clinical presentation and treatment outcome.

Englund, Annika; Glimelius, Ingrid; Rostgaard, Klaus; Smedby, Karin E et al.

Ingår i Acta Oncologica, s. 276-282, 2018

• DOI för Hodgkin lymphoma in children, adolescents and young adults - a comparative study of clinical presentation and treatment outcome.
• Ladda ner fulltext (pdf) av Hodgkin lymphoma in children, adolescents and young adults - a comparative study of clinical presentation and treatment outcome.

High proportions of PD-1⁺ and PD-L1⁺ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome

Hollander, Peter; Kamper, Peter; Smedby, Karin Ekstrom; Enblad, Gunilla et al.

Ingår i Blood Advances, s. 1427-1439, 2017

• DOI för High proportions of PD-1⁺ and PD-L1⁺ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome

Nodular lymphocyte predominant Hodgkin lymphoma in Sweden between 2000 and 2014: an analysis of the Swedish Lymphoma Registry

Molin, Daniel; Linderoth, Johan; Wahlin, Björn E.

Ingår i British Journal of Haematology, s. 449-456, 2017

• DOI för Nodular lymphocyte predominant Hodgkin lymphoma in Sweden between 2000 and 2014: an analysis of the Swedish Lymphoma Registry

Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma

Chen, Robert; Zinzani, Pier Luigi; Fanale, Michelle A.; Armand, Philippe et al.

Ingår i Journal of Clinical Oncology, s. 2125-2132, 2017

• DOI för Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma

High Expression Of Programmed Cell Death Receptor 1 In The Tumor Microenvironment Is Associated With Inferior Event Free Survival In Classical Hodgkin Lymphoma

Hollander, Peter; Kamper, P.; Smedby, K. E.; Enblad, Gunilla et al.

Ingår i Haematologica, s. 1-2, 2016

Hodgkin Lymphoma In Children, Adolescents And Young Adults-A Comparative Study Of Clinical Presentation And Treatment Outcome

Englund, Annika; Glimelius, Bengt; Rostgaard, K.; Eloranta, S. et al.

Ingår i Haematologica, s. 36-36, 2016

Hodgkin Lymphoma In Sweden Since 2000: Better Survival Only In Elderly Women - A Swedish Lymphoma Registry Study

Wahlin, B. E.; Overgaard, N.; Peterson, S.; Digkas, E. et al.

Ingår i Haematologica, s. 22-22, 2016

No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study

Jakobsen, Lasse H; Hutchings, Martin; de Nully Brown, Peter; Linderoth, Johan et al.

Ingår i British Journal of Haematology, s. 236-244, 2016

• DOI för No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study

PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study.

Barrington, Sally F; Kirkwood, Amy A; Franceschetto, Antonella; Fulham, Michael J et al.

Ingår i Blood, s. 1531-1538, 2016

• DOI för PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study.

Prognostic Implications Of An Active, Innate Or Anergic Immune Response In The Hodgkin Lymphoma Tumor Microenvironment

Hollander, Peter; Rostgaard, K.; Smedby, K. E.; Molin, Daniel et al.

Ingår i Haematologica, s. 3-3, 2016

The Importance Of Bone Marrow 18F-Fdg Uptake And Focal Skeletal Lesions On Survival In Patients With Newly Diagnosed Hodgkin Lymphoma

Pedersen, M. A.; Gormsen, L. C.; Kamper, P.; d'Amore, A. et al.

Ingår i Haematologica, s. 42-42, 2016

The role of tumour-infiltrating eosinophils, mast cells and macrophages in Classical and Nodular Lymphocyte Predominant Hodgkin Lymphoma in children

Englund, Annika; Molin, Daniel; Enblad, Gunilla; Karlén, Jonas et al.

Ingår i European Journal of Haematology, s. 430-438, 2016

• DOI för The role of tumour-infiltrating eosinophils, mast cells and macrophages in Classical and Nodular Lymphocyte Predominant Hodgkin Lymphoma in children
• Ladda ner fulltext (pdf) av The role of tumour-infiltrating eosinophils, mast cells and macrophages in Classical and Nodular Lymphocyte Predominant Hodgkin Lymphoma in children

Expression of Intratumoral Forkhead Box Protein 3 in Posttransplant Lymphoproliferative Disorders: Clinical Features and Survival Outcomes

Berglund, David; Kinch, Amelie; Edman, Elin; Backlin, Carin et al.

Ingår i Transplantation, s. 1036-1042, 2015

• DOI för Expression of Intratumoral Forkhead Box Protein 3 in Posttransplant Lymphoproliferative Disorders: Clinical Features and Survival Outcomes

Whole-body diffusion-weighted MRI and (18)F-FDG PET/CT can discriminate between different lymphoma subtypes

Mosavi, Firas; Wassberg, Cecilia; Selling, Jonas; Molin, Daniel et al.

Ingår i Clinical Radiology, s. 1229-1236, 2015

• DOI för Whole-body diffusion-weighted MRI and (18)F-FDG PET/CT can discriminate between different lymphoma subtypes

A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.

Kinch, Amelie; Baecklund, Eva; Backlin, Carin; Ekman, Tor et al.

Ingår i Acta Oncologica, s. 669-679, 2014

• DOI för A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.

Diffusely Increased Bone Marrow 18F-FDG Uptake Is an Independent Predictor of Focal Bone Lesions in Patients with Newly Diagnosed Classical Hodgkin Lymphoma

Gormsen, Lars C.; Wassberg, Cecilia; Molin, Daniel; Kamper, Peter et al.

Ingår i Blood, 2014

Vanishing bile duct-like syndrome in a patient with Hodgkin lymphoma: pathological development and restitution

Hallén, Karin; Sangfelt, Per; Nilsson, Thomas; Nordgren, Hans et al.

Ingår i Acta Oncologica, s. 1271-1275, 2014

• DOI för Vanishing bile duct-like syndrome in a patient with Hodgkin lymphoma: pathological development and restitution

Tissue microarray and digital image analysis: a methodological study with special reference to the microenvironment in Hodgkin lymphoma

Glimelius, Ingrid; Qvarnström, Fredrik; Simonsson, Martin; Ekwall, Anders et al.

Ingår i Histopathology, s. 26-32, 2012

• DOI för Tissue microarray and digital image analysis: a methodological study with special reference to the microenvironment in Hodgkin lymphoma

Long term risk of infections in Hodgkin lymphoma long-term survivors

Andersson, Anne; Enblad, Gunilla; Gustavsson, Anita; Erlanson, Martin et al.

Ingår i British Journal of Haematology, s. 661-663, 2011

• DOI för Long term risk of infections in Hodgkin lymphoma long-term survivors

Pediatric Organ Transplantation and Risk of Premalignant and Malignant Tumors in Sweden

Simard, J. F.; Baecklund, Eva; Kinch, Amelie; Brattström, C. et al.

Ingår i American Journal of Transplantation, s. 146-151, 2011

• DOI för Pediatric Organ Transplantation and Risk of Premalignant and Malignant Tumors in Sweden

Predictors of histology, tissue eosinophilia and mast cell infiltration in Hodgkin's Lymphoma: a population-based study

Glimelius, Ingrid; Rubin, Jenny; Rostgaard, Klaus; Amini, Rose Marie et al.

Ingår i European Journal of Haematology, s. 208-216, 2011

• DOI för Predictors of histology, tissue eosinophilia and mast cell infiltration in Hodgkin's Lymphoma: a population-based study

The effect of Eosinophil cationic protein (ECP) on Hodgkin lymphoma cell lines

Glimelius, Ingrid; Rubin, Jenny; Fischer, Marie; Molin, Daniel et al.

Ingår i Experimental Hematology, s. 850-858, 2011

• DOI för The effect of Eosinophil cationic protein (ECP) on Hodgkin lymphoma cell lines

Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients

Abdul Qadhr, Göran; Molin, Daniel; Åström, Gunnar; Suurküla, Madis et al.

Ingår i Acta Radiologica, s. 173-180, 2011

• DOI för Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients

A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)

Enciso-Mora, Victor; Broderick, Peter; Ma, Yussanne; Jarrett, Ruth F. et al.

Ingår i Nature Genetics, s. 1126-1130, 2010

• DOI för A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)

Change of initial staging at early remission evaluation with FDG-PET/CT in Hodgkin lymphoma: A report of two cases

Molin, Daniel; Hagberg, Hans; Suurküla, Madis; Åström, Gunnar

Ingår i Acta Oncologica, s. 526-528, 2010

• DOI för Change of initial staging at early remission evaluation with FDG-PET/CT in Hodgkin lymphoma: A report of two cases

Framgångens baksida: Sena biverkningar av strålbehandling vid Hodgkins lymfom

Molin, Daniel

Ingår i Läkartidningen, s. 2731-2732, 2010

Framgångens baksida: Sena biverkningar av strålbehandling vid Hodgkins lymfom

Molin, Daniel

Ingår i Läkartidningen, s. 2731-2732, 2010

Mast cells in squamous cell esophageal carcinoma and clinical parameters

Tinge, Beatrice; Molin, Daniel; Bergqvist, Michael; Ekman, Simon et al.

Ingår i Cancer Genomics & Proteomics, s. 25-29, 2010

Serum YKL-40 and interleukin 6 levels in Hodgkin lymphoma

Biggar, Robert J.; Johansen, Julia S.; Smedby, Karin Ekström; Rostgaard, Klaus et al.

Ingår i Clinical Cancer Research, s. 6974-8, 2008

• DOI för Serum YKL-40 and interleukin 6 levels in Hodgkin lymphoma

Cigarette smoking and risk of Hodgkin lymphoma: a population-based case-control study

Hjalgrim, Henrik; Ekström-Smedby, Karin; Rostgaard, Klaus; Amini, Rose-Marie et al.

Ingår i Cancer Epidemiology, Biomarkers and Prevention, s. 1561-1566, 2007

• DOI för Cigarette smoking and risk of Hodgkin lymphoma: a population-based case-control study

Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma

Hjalgrim, Henrik; Smedby, Karin Ekström; Rostgaard, Klaus; Molin, Daniel et al.

Ingår i Cancer Research, s. 2382-2388, 2007

• DOI för Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma

Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma

Hedström, Gustaf; Berglund, Mattias; Molin, Daniel; Fischer, Marie et al.

Ingår i British Journal of Haematology, s. 68-71, 2007

• DOI för Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma

The potential role of innate immunity in the pathogenesis of Hodgkin's lymphoma

Enblad, Gunilla; Molin, Daniel; Glimelius, Ingrid; Fischer, Marie et al.

Ingår i Hematology/Oncology Clinics of North America, s. 805-823, 2007

• DOI för The potential role of innate immunity in the pathogenesis of Hodgkin's lymphoma

IL-9 expression contributes to the cellular composition in Hodgkin lymphoma

Glimelius, Ingrid; Edström, Annika; Amini, Rose-Marie; Fischer, Marie et al.

Ingår i European Journal of Haematology, s. 278-283, 2006

• DOI för IL-9 expression contributes to the cellular composition in Hodgkin lymphoma

Angiogenesis and mast cells in Hodgkin lymphoma

Glimelius, Ingrid; Edström, Annika; Fischer, Marie; Nilsson, Gunnar et al.

Ingår i Leukemia, s. 2360-2362, 2005

• DOI för Angiogenesis and mast cells in Hodgkin lymphoma

Community-acquired pneumonia and bacteraemia in a healthy young woman caused by methicillin-resistant Staphylococcus aureus (MRSA) carrying the genes encoding Panton-Valentine leukocidin (PVL).

Torell, Erik; Molin, Daniel; Tano, Eva; Ehrenborg, Christian et al.

Ingår i Scand J Infect Dis, s. 902-4, 2005

Bystander cells and prognosis in Hodgkin lymphoma. Review based on a doctoral thesis.

Molin, Daniel

Ingår i Ups J Med Sci, s. 179-228, 2004

Increased serum levels of Interleukin-9 correlates with negative prognostic factors in Hodgkin's lymphoma

Fischer, Marie; Molin, Daniel; Bijman, Marcel; Cormont, Francoise et al.

Ingår i Leukemia, s. 2513, 2003

Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma

Molin, Daniel; Edström, Annika; Glimelius, Ingrid; Glimelius, Bengt et al.

Ingår i British Journal of Haematology, s. 122-124, 2002

• DOI för Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma

Comprehensive blood plasma proteomics identifies VSIG4 and CD169 as prospective biomarkers for high-risk of early relapse in mantle cell lymphoma

Nylund, Patrick; Selvin, Tove; Nikkarinen, Anna; Ly, Ann-Marie et al.

NaN

Plasma Protein Profiling using Multiplex Extension Assay in Diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP: A descriptive study

Abu Sabaa, Amal; Mörth, Charlott; Molin, Daniel; Freyhult, Eva et al.

NaN

Real-life data on morbidity and cause-specific mortality after combined modality treatment for Hodgkin lymphoma 2006-2015.

Lagerlöf, Ingemar; Wikman, Per; Enblad, Gunilla; Goldkuhl, Christina et al.

NaN

Second cancer is the leading cause of death, with no increase of cardiovascular deaths, after combined modality Hodgkin lymphoma treatment

Lagerlöf, Ingemar; Fohlin, Helena; Enblad, Gunilla; Glimelius, Bengt et al.

NaN